Analysed INVIVYD INC (IVVD:NASDAQ) News Sources
Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine Co-Administration
09-06-2026
yahoo.com
Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine
16-06-2026
yahoo.com
Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA
06-07-2026
yahoo.com
What is the current price of INVIVYD INC (IVVD:NASDAQ)?
The current price of INVIVYD INC (IVVD:NASDAQ) is $0.6114.
INVIVYD INC (IVVD:NASDAQ) absolute price change since previous trading day?
The absolute price change of INVIVYD INC (IVVD:NASDAQ) since the previous trading day is $0.0022.
INVIVYD INC (IVVD:NASDAQ) percentage price change since previous trading day?
The percentage price change of INVIVYD INC (IVVD:NASDAQ) since the previous trading day is 0.3611%.
What is the most recent average sentiment score for INVIVYD INC (IVVD:NASDAQ)?
The most recent average sentiment score for INVIVYD INC (IVVD:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for INVIVYD INC (IVVD:NASDAQ)?
The most recent sentiment for INVIVYD INC (IVVD:NASDAQ) is .
SEC-8K** Filing Available For INVIVYD INC (IVVD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.